Print

Conference Tracks

Track 1: Basic and Clinical Sciences

Basic science topics covered in this track will encompass, but not be limited to, mucosal immunity to HIV, HIV transmission, TB/HIV co-infection, viral fitness and the role of host factors and host genetics. This track will also focus on new advances in HIV vaccines, neutralizing and non-neutralizing antibody therapies, cure strategies, pre-exposure prophylaxis (PrEP) and microbicide development, including pre-clinical studies. Clinical science topics covered by this track will include issues relating to antiretroviral (ARV) treatment, including new drugs and salvage therapy, in adult and paediatric infections; ARV complications including immune reconstitution inflammatory syndrome, drug resistance, side effects and drug interactions. Strategies for promoting long-term health in virally suppressed individuals including management of non-communicable diseases will be discussed. Approaches to treatment for vulnerable groups such as injecting drug users, men-who-have sex with men and sex workers will be explored, as well as novel ways of promoting treatment or PrEP adherence. This track will also include presentations and discussions on new developments in laboratory and diagnostic tools, nutrition, and the role of complementary and traditional medicines.

Track 2: Epidemiology, Prevention and Public Health

Epidemiological topics covers by this track will include issues related to the dynamics of the HIV epidemic, both at the molecular and population level. It will also cover the full spectrum of methodological and technological advances in surveillance, mathematical modeling and transmission dynamics. Prevention topics will focus on aspects of treatment (i.e., PreP, treatment as prevention, MMC and PMTCT) as well as early HIV testing and linkage-to-care. The link between TB, HIV treatment and prevention will also be covered by this track. Given the central role of public health programmes to provide prevention and treatment, presentations related to operational and implementation science will also be covered in this track.

Track 3: Social, Political, Economic and Health Systems

This track explores the social, political, economic and health systems issues that act as barriers or facilitators to an individual’s or community’s response to the HIV epidemic. Models of cross-sectorial interventions, as well as social change programmes and examinations of the political and economic environment as they impact on the epidemic will be explored. Presentations relating to the links between HIV and AIDS, and substance use, poverty, education, gender-based violence, patriarchy and other living social and environmental issues will be discussed.

Track 4: Ethics, Marginalization and the Protection of Human Rights

This track provides an opportunity for conference attendees to examine and share issues relating to marginalized groups such as sex workers, LGBTIQA, miners, farm workers and travelers, and their challenges and successes that relate to the AIDS epidemic. It offers the opportunity for marginalized communities to be center stage and engage with how the marginalization has affected the response to the epidemic and approaches to overcoming these challenges.

Track 5: Best Practices: Programmes, Communications and Community Engagement

This track will focus on issues relating to ordinary people and communities who are broadly defined to include people living with HIV, impacted by HIV and, people vulnerable to HIV infection and those who interact with communities on issues relating to HIV and AIDS. Organization, collective action and sustainable community based approaches and the means by which these are achieved will be highlighted. Communication in recent times includes a range of tools from traditional tools such as books, radio and television to cell phone apps, and social media. This track will provide a platform to engage with evidence of success and challenges relating to the use of these tools and mobilising and managing resources to increase control of the AIDS epidemic.